CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 70 filers reported holding CARDIFF ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,138 | -44.1% | 84,272 | -40.8% | 0.00% | -100.0% |
| Q2 2023 | $209,369 | -67.9% | 142,428 | -63.9% | 0.00% | -50.0% |
| Q1 2023 | $651,740 | +259557.4% | 394,994 | +120.0% | 0.00% | +100.0% |
| Q4 2022 | $251 | -99.9% | 179,543 | +7.8% | 0.00% | 0.0% |
| Q3 2022 | $256,000 | -24.9% | 166,534 | +7.3% | 0.00% | 0.0% |
| Q2 2022 | $341,000 | -57.6% | 155,190 | -52.2% | 0.00% | -50.0% |
| Q1 2022 | $805,000 | +362.6% | 324,460 | +1140.0% | 0.00% | +100.0% |
| Q2 2021 | $174,000 | – | 26,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |